journal article·2021-07-01Open access

A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellular traps (NETs)-mediated collective tumor invasion

Vikram Surendran, Dylan Rutledge, Ramair Colmon, Arvind Chandrasekaran

Biofabrication· Volume 13· Issue 3

Abstract

Abstract Neutrophils are the most abundant type of leukocytes in the blood, traditionally regarded as the first immune responders to infections and inflammations. In the context of tumors, neutrophils have been shown to possess both tumor-promoting and tumor-limiting properties. A better understanding of the inter-cellular dynamics between the neutrophils and aggregated tumors could possibly shed light on the different modalities of neutrophil involvement in tumor progression. To study in-vitro the interactional dynamics of neutrophils and growing tumor aggregates, in this work, we engineered a novel, microfluidics-integrated, three-dimensional (3D) tumor-immune microenvironment (TIME)-on-Chip device, and we investigated the effect of neutrophils on the inception of collective 3D invasion of ovarian tumor cells. Herein, tumor spheroids generated and cultured on hydrogel based multi-microwell plates, and embedded within collagen matrix of defined thickness, were magnetically hybrid-integrated with a 3D bioprinting enabled microfluidic system fabricated on a porous membrane and carrying neutrophils. This setting recreated a typical TIME in-vitro to model dynamic neutrophil migration and 3D tumor invasion. Using this device, we observed that neutrophils respond to the growing tumor spheroids through both chemotaxis and generation of neutrophil extracellular traps (NETs). The formation of NETs stimulated the reciprocation of tumor cells from their aggregated state to collectively invade into the surrounding collagen matrix, in a manner more significant compared to their response to known tumor-derived stimulants such as transforming growth factor and Interleukin- 8. This effect was reversed by drug-induced inhibition of NETs formation, suggesting that induction of NETs by cancer cells could be a pro-migratory tumor behavior. Further, we additionally report a previously unidentified, location-dictated mechanism of NETosis, in which NETs formation within the stromal extracellular collagen matrix around the spheroids, and not tumor-contacted NETs, is important for the induction of collective invasion of the ovarian tumor cells, thus providing a rationale for new anti-tumor therapeutics research.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Immune cells in cancer · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Microfluidic system for modelling 3D tumour invasion into surrounding stroma and drug screening10.1088/1758-5090/aac70c ↗
2. Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects10.1172/jci.insight.128008 ↗
3. Understanding the tumor immune microenvironment (TIME) for effective therapy10.1038/s41591-018-0014-x ↗
4. Neutrophils in the tumor microenvironment10.1016/j.it.2015.11.008 ↗
5. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma10.1038/bjc.2017.401 ↗
6. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response10.1186/s12865-018-0251-2 ↗
7. Prognostic significance of neutrophil–lymphocyte ratio (NLR) in patients with ovarian cancer: a systematic review and meta-analysis10.1097/MD.0000000000017475 ↗
8. Neutrophils: important contributors to tumor progression and metastasis10.1007/s10555-015-9594-9 ↗
9. Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer10.1038/s41416-018-0198-3 ↗
10. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis10.1016/j.bbrc.2018.05.024 ↗
11. Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer10.1038/bjc.2013.167 ↗
12. Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-0310.1038/sj.bjc.6605348 ↗
13. Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer10.1007/s10549-011-1799-1 ↗
14. Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group10.1016/j.ygyno.2014.03.013 ↗
15. Early onset neutropenia: a useful predictor of chemosensitivity and favorable prognosis in patients with serous ovarian cancer10.1186/s12885-020-6609-x ↗
16. Prognostic value of chemotherapy-induced neutropenia at the first cycle in invasive breast cancer10.1097/MD.0000000000003240 ↗
17. Chemotherapy-induced neutropenia as a prognostic and predictive marker of outcomes in solid-tumor patients10.1007/s40265-018-0909-3 ↗
18. Neutrophil granulocytes in ovarian cancer-induction of epithelial-to-mesenchymal-transition and tumor cell migration10.7150/jca.14169 ↗
19. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment10.1172/jci.insight.122311 ↗
20. Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum10.1084/jem.20181170 ↗
21. TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils10.1038/onc.2016.217 ↗
22. Tumor-contacted neutrophils promote metastasis by a CD90-TIMP-1 juxtacrine–paracrine loop10.1158/1078-0432.CCR-18-2544 ↗
23. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity10.3892/ijo.2018.4504 ↗
24. Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer10.3390/cancers12020505 ↗
25. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration10.4049/jimmunol.164.5.2769 ↗
26. LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer10.7150/jca.41035 ↗
27. Neutrophil plasticity in the tumor microenvironment10.1182/blood-2018-11-844548 ↗
28. Neutrophils as a therapeutic target in cancer10.3389/fimmu.2019.01710 ↗
29. Neutrophil diversity and plasticity in tumour progression and therapy10.1038/s41568-020-0281-y ↗
30. Neutrophil extracellular traps kill bacteria10.1126/science.1092385 ↗
31. Neutrophil extracellular traps in immunity and disease10.1038/nri.2017.105 ↗
32. New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation10.3389/fimmu.2016.00302 ↗
33. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis10.1172/JCI67484 ↗
34. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress10.1158/0008-5472.CAN-15-1591 ↗
35. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps10.1126/scitranslmed.aag1711 ↗
36. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice10.1126/science.aao4227 ↗
37. Tumor cell dissemination: emerging biological insights from animal models and cancer patients10.1016/j.ccr.2013.04.017 ↗
38. On the origin of cancer metastasis10.1615/CritRevOncog.v18.i1-2.40 ↗
39. Early tumor dissemination, but late metastasis: insights into tumor dormancy10.1172/JCI43424 ↗
40. A collective route to metastasis: seeding by tumor cell clusters10.1126/science.aaf6546 ↗
41. Senescent tumor cells lead the collective invasion in thyroid cancer10.1038/ncomms15208 ↗
42. The role of tumor microenvironment in collective tumor cell invasion10.2217/fon-2016-0501 ↗
43. An emerging tumor invasion mechanism about the collective cell migration
44. Inhibition of neutrophil infiltration into A549 lung tumors in vitro in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth10.1002/ijc.25987 ↗
45. Cxcr1 and cxcr2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity10.1016/j.immuni.2020.03.001 ↗
46. Preparation of hydrogel substrates with tunable mechanical properties10.1002/0471143030.cb1016s47 ↗
47. Magnetic microboats for floating, stiffness tunable, air–liquid interface epithelial cultures10.1039/C9LC00267G ↗
48. Tumor-vasculature-on-a-chip for investigating nanoparticle extravasation and tumor accumulation10.1021/acsnano.8b06846 ↗
49. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening10.1038/s41598-018-35216-7 ↗
50. Micropocket hydrogel devices for all-in-one formation, assembly, and analysis of aggregate-based tissues10.1088/1758-5090/ab30b4 ↗
51. Bioprinting of 3D tissues/organs combined with microfluidics10.1039/C8RA03022G ↗
52. Pluronic F127 hydrogel characterization and biofabrication in cellularized constructs for tissue engineering applications10.1016/j.procir.2015.11.001 ↗
53. Temporal gradients limit the accumulation of neutrophils toward sources of chemoattractant10.1038/micronano.2016.67 ↗
54. High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease10.18632/oncotarget.25098 ↗
55. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy10.1038/s41419-017-0061-0 ↗
56. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer10.1038/s41388-018-0317-x ↗
57. Analysis of cell migration within a three-dimensional collagen matrix10.3791/51963 ↗
58. Three-dimensional (3D) tumor spheroid invasion assay10.3791/52686 ↗
59. TGF-β isoforms induce EMT independent migration of ovarian cancer cells10.1186/s12935-014-0072-1 ↗
60. Interleukin-8 promotes human ovarian cancer cell migration by epithelial–mesenchymal transition induction in vitro10.1007/s12094-014-1240-4 ↗
61. TGF-β mediated cell adhesion dynamics and epithelial to mesenchymal transition in 3D and 2D ovarian cancer models10.1101/465617 ↗
62. Molecular mechanisms of epithelial–mesenchymal transition10.1038/nrm3758 ↗
63. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers10.3892/ijo.2014.2695 ↗
64. Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer10.1038/srep05646 ↗
65. The impact of proliferation-migration tradeoffs on phenotypic evolution in cancer10.1038/s41598-019-39636-x ↗
66. Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas10.1038/s41598-019-41941-4 ↗
67. Super-low dose lipopolysaccharide dysregulates neutrophil migratory decision-making10.3389/fimmu.2019.00359 ↗
68. Fluid shear stress increases neutrophil activation via platelet-activating factor10.1016/j.bpj.2014.04.001 ↗
69. Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer10.1097/SLA.0000000000002058 ↗
70. Tumor-associated neutrophils: friend or foe?10.1093/carcin/bgs123 ↗
71. Stiffness analysis of 3D spheroids using microtweezers10.1371/journal.pone.0188346 ↗
72. Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock10.1016/j.biomaterials.2020.119836 ↗
73. Neutrophil extracellular trap-associated ceacam1 as a putative therapeutic target to prevent metastatic progression of colon carcinoma10.4049/jimmunol.1900240 ↗
74. Inflamed neutrophils sequestered at entrapped tumor cells via chemotactic confinement promote tumor cell extravasation10.1073/pnas.1715932115 ↗
75. Phenotypic variations and differential migration of NIH: OVCAR-3 ovarian carcinoma cells isolated from athymic mice10.1007/BF00132204 ↗
76. Oxygen diffusion in ellipsoidal tumour spheroids10.1098/rsif.2018.0256 ↗
77. Long-term monitoring of live cell proliferation in presence of PVP‐Hypericin: a new strategy using ms pulses of LED and the fluorescent dye CFSE10.1111/j.1365-2818.2011.03555.x ↗
78. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells10.1186/s13048-017-0319-2 ↗
79. Differential signalling and kinetics of neutrophil extracellular trap release revealed by quantitative live imaging10.1038/s41598-017-06901-w ↗
80. LTB4 is a signal-relay molecule during neutrophil chemotaxis10.1016/j.devcel.2012.02.003 ↗
81. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer10.1038/nrc4019 ↗
82. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils10.1002/jcp.1041400226 ↗
83. IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils-fibroblasts interaction in psoriasis10.2478/v10039-010-0037-0 ↗
84. Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells10.1002/pros.21146 ↗
85. Phorbol myristate acetate suppresses breast cancer cell growth via down-regulation of P-Rex1 expression10.1007/s13238-016-0261-x ↗
86. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens10.1038/ni.2987 ↗
87. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature10.1038/ncomms7673 ↗
88. Intravascular survival and extravasation of tumor cells10.1016/j.ccell.2017.07.001 ↗
89. The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity10.3389/fonc.2018.00431 ↗
90. Neutrophils and NETS in modulating acute and chronic inflammation10.1182/blood-2018-11-844530 ↗
91. 3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry10.1038/s41467-017-01556-7 ↗
92. The extracellular matrix modulates the metastatic journey10.1016/j.devcel.2019.03.026 ↗
93. Neutrophil extracellular traps sequester circulating tumor cells via β1-integrin mediated interactions10.1002/ijc.30635 ↗
94. Neutrophil extracellular trap fragments stimulate innate immune responses that prevent lung transplant tolerance10.1111/ajt.15163 ↗
95. Integrin associated proteins differentially regulate neutrophil polarity and directed migration in 2D and 3D10.1007/s10544-015-9998-x ↗
96. Drug discovery goes three-dimensional: goodbye to flat high-throughput screening?10.1089/adt.2015.647 ↗
97. Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read‐outs10.1002/biot.201600505 ↗
98. 3D tumor spheroids: an overview on the tools and techniques used for their analysis10.1016/j.biotechadv.2016.11.002 ↗
99. Three-dimensional culture systems in cancer research: focus on tumor spheroid model10.1016/j.pharmthera.2016.03.013 ↗
100. 3D cell culture systems modeling tumor growth determinants in cancer target discovery10.1016/j.addr.2014.03.001 ↗